Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 934 of 5804
-
Nurse visits to new parents may stop child abuse before it starts
Prevention OngoingThe aim of this randomized controlled trial (RCT) is to conduct a second, independent evaluation the implementation and impact of the Durham Connects (DC) brief universal nurse home-visiting program to prevent child maltreatment and improve child and family health and well-being.…
Phase: NA • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Can interferon keep melanoma from coming back after surgery?
Disease control CompletedThe goal of this clinical trial is to learn if adding alpha interferon to standard treatment works to prevent skin melanoma from coming back after surgery. The study will also learn if different doses of alpha interferon work better than others. The main questions it aims to ans…
Phase: PHASE2 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for lymphoma patients who Can't handle standard chemo
Disease control CompletedThe purpose of this trial is to compare the efficacy and safety of Inotuzumab Ozogamicin in combination with R-CVP with that of R-G-CVP for the treatment of Diffuse Large B Cell Lymphoma (DLBCL) in a population of patients not suitable for anthracycline based chemotherapy. There…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New chemo cocktail shows promise in myeloma stem cell transplants
Disease control CompletedA number of strategies have been proposed to improve the outcome of ASCT. The three main strategies are to incorporate novel agents into the induction regimen, using maintenance therapy following ASCT and the final strategy is to enhance conditioning regimens. Investigators woul…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Massive uganda study aims to uncover true sickle cell burden
Knowledge-focused Recruiting nowIt is estimated that over 250,000 babies are born with sickle cell disease (SCD) annually in sub-Saharan Africa, and only 10% - 50% of them survive beyond five years of age. Data describing the magnitude of the sickle cell problem are lacking in most African countries. The availa…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Liver patients get brain protection: antibiotic may stop confusion after TIPS
Prevention CompletedTIPS has been used for 20 years, as a means of reducing portal pressure in patients with cirrhosis and portal hypertension related complications. TIPS proved more effective than alternative treatments in controlling or preventing variceal bleeding and refractory ascites. The main…
Phase: PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New combo shows promise for lung cancer patients
Disease control CompletedThe primary purpose of this study is to compare the efficacy of the study drug LY2875358, given together with erlotinib, against erlotinib, alone. Participants will have Non-Small Cell Lung Cancer (NSCLC) that has advanced to Stage IV. Participants should not have been treated wi…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Could an arthritis drug ease Sjögren's symptoms?
Disease control CompletedPrimary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized by lymphocytic infiltration leading to destruction of acinar and ductal cells and loss of glandular parenchyma. The main symptoms of pSS are dry eyes and dry mouth, diffuse pain, and fatigue. One thir…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo aims to keep rare lymphoma at bay after transplant
Disease control CompletedThe purpose of this study is to test the benefit of a chemotherapy drug called romidepsin in patients with T Cell Non-Hodgkin Lymphoma (T NHL) who have undergone autologous transplantation.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Heart artery study tests smarter imaging to prevent attacks
Disease control CompletedThe objective of this trial is to compare the clinical outcomes and cost-effectiveness of 2 therapeutic strategies, one based on coronary angiography guidance and the other based on coronary angiography with fractional flow reserve (FFR) in multivessel coronary artery disease pat…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a cancer drug shrink endometrial tumors?
Disease control CompletedThis phase II trial studies how well cabozantinib s-malate works in treating patients with endometrial cancer that has come back (recurrent) or has spread to other places in the body (metastatic). Cabozantinib s-malate may stop the growth of tumor cells by blocking some of the en…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for tough lymphoma: targeted drug shows promise
Disease control OngoingThis phase II trial studies how well ibrutinib works in treating patients with follicular lymphoma that has come back after a period of improvement or does not respond to treatment. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell grow…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could an antibiotic beat eye cancer? new trial tests doxycycline for lymphoma
Disease control CompletedObjective of this trial is to establish the efficacy of an upfront targeted therapy consisting of Chlamydophila psittaci (Cp)-eradicating therapy with prolonged administration of doxycycline followed by eradication monitoring and antibiotic re-treatment at infection re-occurrence…
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could drug holidays improve thyroid cancer treatment?
Disease control CompletedThe objective of this study is to determine the feasibility of pazopanib treatment interruption with reintroduction at progression in iodine refractory progressive Differentiated Thyroid Cancer (DTC) patients as compared to pazopanib continuous administration.
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain zaps reveal secrets of movement in Parkinson's
Knowledge-focused Recruiting nowThis program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Brain zaps for depression? tiny study hopes to lift the fog
Symptom relief OngoingThis research study will investigate the safety, tolerability, and benefit of bilateral deep brain stimulation (DBS) to the lateral habenula in subjects with treatment-resistant major depression (TRD) secondary to either nonpsychotic unipolar major depressive disorder (MDD), or b…
Phase: NA • Sponsor: Wayne Goodman MD • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New radiation technique aims to spare heart in breast cancer patients
Disease control OngoingThe purpose of this study is to look at the rates of acute and long term adverse events of postoperative proton radiotherapy for complex loco-regional irradiation in women with loco-regionally advanced breast cancer. This study specifically includes longitudinal follow up to asse…
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 13:57 UTC
-
Diet before chemo may cut side effects in breast and prostate cancer
Symptom relief OngoingThis randomized phase II trial studies how well a controlled low calorie diet works in reducing side effects and increasing response to chemotherapy in patients with breast or prostate cancer. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, e…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New scope treatment eases swallowing woes
Disease control CompletedPOEM has recently described as an alternative treatment for achalasia in humans. In this procedure the esophageal sphincter is incised through a submucosal tunnel in the esophagus. In this study we aim to perform POEM on achalasia patients.
Phase: NA • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Less invasive heart valve fix vs. open surgery: which is better for High-Risk patients?
Disease control ENROLLING_BY_INVITATIONThe mechanical intervention is treating aortic valve stenosis (AVS) which may be performed using the standard open surgical approach for aortic valve replacement (AVR) or transcatheter aortic valve implantation (TAVI). The key question of this study is to establish the difference…
Sponsor: Centre Cardiologique du Nord • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC